Evidence map›Paper›PMID 30621713›Full record

ArticleVirology journal2019

Complete genome sequences of Aeromonas and Pseudomonas phages as a supportive tool for development of antibacterial treatment in aquaculture.

Joanna Kazimierczak, Ewelina Agnieszka Wójcik, Jolanta Witaszewska, Arkadiusz Guziński, Elżbieta Górecka, Małgorzata Stańczyk, Edyta Kaczorek, Andrzej Krzysztof Siwicki, Jarosław Dastych

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Bacteriophages AgainstViruses · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Bacteriophages in the Control ofAntibiotics (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Phage-Mediated Control ofFrontiers in microbiology · 2021
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Joanna KazimierczakProteon Pharmaceuticals, Lodz, Poland.
Ewelina Agnieszka WójcikProteon Pharmaceuticals, Lodz, Poland. ewojcik@proteonpharma.com.
Jolanta WitaszewskaProteon Pharmaceuticals, Lodz, Poland.
Arkadiusz GuzińskiProteon Pharmaceuticals, Lodz, Poland.
Elżbieta GóreckaProteon Pharmaceuticals, Lodz, Poland.
Małgorzata StańczykProteon Pharmaceuticals, Lodz, Poland.
Edyta KaczorekDepartment of Microbiology and Clinical Immunology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
Andrzej Krzysztof SiwickiDepartment of Microbiology and Clinical Immunology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
Jarosław DastychProteon Pharmaceuticals, Lodz, Poland.
University of Warmia and Mazury in Olsztyn · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAquaculture is the fastest growing sector of food production worldwide. However, one of the major reasons limiting its effectiveness are infectious diseases among aquatic organisms resulting in vast economic losses. Fighting such infections with chemotherapy is normally used as a rapid and effective treatment. The rise of antibiotic resistance, however, is limiting the efficacy of antibiotics and creates environmental and human safety concerns due to their massive application in the aquatic environment. Bacteriophages are an alternative solution that could be considered in order to protect fish against pathogens while minimizing the side-effects for the environment and humans. Bacteriophages kill bacteria via different mechanisms than antibiotics, and so fit nicely into the 'novel mode of action' concept desired for all new antibacterial agents.

methodsThe bacteriophages were isolated from sewage water and characterized by RFLP, spectrum of specificity, transmission electron microscopy (TEM) and sequencing (WGS). Bioinformatics analysis of genomic data enables an in-depth characterization of phages and the choice of phages. This allows an optimised choice of phage for therapy, excluding those with toxin genes, virulence factor genes, and genes responsible for lysogeny.

resultsIn this study, we isolated eleven new bacteriophages: seven infecting Aeromonas and four infecting Pseudomonas, which significantly increases the genomic information of Aeromonas and Pseudomonas phages. Bioinformatics analysis of genomic data, assessing the likelihood of these phages to enter the lysogenic cycle with experimental data on their specificity towards large number of bacterial field isolates representing different locations.

conclusionsFrom 11 newly isolated bacteriophages only 6 (25AhydR2PP, 50AhydR13PP, 60AhydR15PP, 22PfluR64PP, 67PfluR64PP, 71PfluR64PP) have a potential to be used in phage therapy due to confirmed lytic lifestyle and absence of virulence or resistance genes.

Indexed as

Genome, ViralAeromonasAnimalsAnti-Bacterial AgentsAquacultureBacteriophagesComputational BiologyDNA, ViralFishesHost SpecificityPhage TherapyPseudomonas PhagesSequence Analysis, DNASewageWhole Genome SequencingAnti-Bacterial AgentsDNA, ViralSewageAeromonas hydrophilaAquacultureBacteriophagesPseudomonas fluorescensWGS

Identifiers

PMID30621713
PMCPMC6325676
OpenAlexW2909022982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.